Surgery – Magnetic field applied to body for therapy
Reexamination Certificate
2002-10-09
2004-01-20
Gilbert, Samuel G. (Department: 3736)
Surgery
Magnetic field applied to body for therapy
Reexamination Certificate
active
06679827
ABSTRACT:
BACKGROUND OF THE INVENTION
A central problem in cancer treatment is that of preserving healthy tissue while destroying cancerous tissue. Although radiation therapy generally involves the focusing of radiation on a tumor, at least some healthy tissue generally is located in the irradiated field. This healthy tissue is exposed to and to some degree damaged by the radiation. In chemotherapy healthy tissue is exposed to the chemotherapy agent and may be damaged.
Moreover, research has shown that much of the effect of radiation therapy and a substantial component of some approaches to chemotherapy are mediated by free radical effects in tumor tissue. The mechanisms whereby free radicals produce tumor cell death include direct enzymatic effects, DNA damage and induction of apoptotic pathways.
Our understanding of the physics and chemistry of free radicals and paired radicals has gradually increased over the past ten years. A free radical is any chemical species capable of an independent existence that has an unpaired electron in its valence shell. The presence of an unpaired electron in the valence shell causes free radicals to be paramagnetic and exhibit magnetic properties when exposed to a magnetic field.
Free radicals may be formed by any of several mechanisms including but not limited to:
Ultraviolet induced homolytic fission as may be encountered in laser ablation therapy of tumors;
Specific chemical reactions as encountered with pharmacological chemotherapy e.g. bleomycin;
Ionizing radiation as the result of external beam irradiation, antibody directed or site selective radio-nucleotide administration or through implantation radiotherapy e.g. prostatic brachyotherapy;
Thermal induction as in hyperthermic therapy; or
Ultrasound induced acoustic cavitation.
Free radicals once generated may recombine. The biologic effects of free radicals in tissue are determined by the net reactive fraction namely the “escape” population that does not recombine rapidly. Factors, which influence pair recombination, include the viscosity of the reaction environment, temperature, bystander effects and the quantum state of the free radical. The quantum state of the free radical is defined by the applicable Schrodinger equation (H&PSgr;=E&PSgr;) where H is a Hamiltonian operator and &PSgr; are sets of wave functions (Eigenfunctions). The Eigenfunctions are defined by a set of four quantum numbers: n-the principal quantum number, 1-the orbital quantum number, M
1-
the magnetic quantum number and M
s-
the spin quantum number. Of particular significance to this discussion is the spin quantum number.
The spin quantum number for an unpaired orbital electron can assume one of two values either +½ or −½. The wave distribution function determined by spin quantitization is a vector quantity and subject to influence by a superimposed magnetic field. When two electrons share an orbital space they must have opposite spin polarity. This phenomenon is dictated by the Pauli Exclusion Principal that postulates that no two electrons can occupy the same quantum state.
Spin polarity is conventionally referred to as up spin (↑) +½ or down spin (↓)−½. Shared valence electrons in the formation of chemical bonds also must have opposite spin polarity. When covalent bonds are severed as in the formation of free radicals spin polarity is preserved.
The unpaired electron in the valence orbital of a free radical in a magnetic field will precess in a manner comparable to Larmor precession described for charged particles in classic electrodynamics. Quantum precession leads to spin phase transitions between the singlet state where antiparallel spin vectors apply and triplet states where parallel spin vectors apply. The singlet state is favorable for recombination because antiparallel spin orientation is preserved and a covalent bond can be established. Triplet state configurations are unfavorable for recombination because parallel spin orientation is induced. In a magnetic field there are three triplet state configurations, which are vector quantities that due to precession in the magnetic field are no longer energy equivalent and are said to be nondegenerate.
The strength of the applied magnetic field, which maximizes the spin phase mixing effect, is dependent on the quantum state of the free radical or the system of free radicals. In general optimum phase mixing is achieved at relatively low magnetic field strengths (0.1-10.0 mTesla) within the hyperfine coupling energy levels of the radical pair.
The singlet state (S
1
) characterized by antiparallel spin vectors will prevail in the absence of a magnetic field when homolytic fission of a covalent bond occurs to form a free radical pair. In the presence of a magnetic field of appropriate strength, the triplet states, T
−1
, T
0
and T
−1
are equally probable energy states and are distinct and nondegenerate. The theoretic distribution between singlet and triplet states will be 25% singlet and 75% triplet. Such a distribution will theoretically increase the effective concentration of escape radicals by 75%. In experimental situations the yield is limited by non-quantum factors including viscosity effects, temperature, diffusion and bystander effects. However, increases in escape radical reactivity of 20-40% are documented in experimental systems where free radical escape reactions are measured.
SUMMARY
The present invention is a method of treating a tumor in which an elevated concentration of free radicals is created in the tumor by one of several methods described. In addition, a magnetic field is created that traverses the tumor and that inhibits the recombination of the free radicals in the tumor enhancing escape radical reactivity, which results in enhanced tumoricidal effect.
REFERENCES:
patent: 4665898 (1987-05-01), Costa et al.
patent: 5072739 (1991-12-01), John
patent: 5087336 (1992-02-01), Liboff et al.
patent: 5099756 (1992-03-01), Franconi et al.
patent: 5156587 (1992-10-01), Montone
patent: 5236410 (1993-08-01), Granov et al.
patent: 5312534 (1994-05-01), Liboff et al.
patent: 5437600 (1995-08-01), Liboff et al.
patent: 5681845 (1997-10-01), Janzen et al.
patent: 5718246 (1998-02-01), Vona
patent: 5919679 (1999-07-01), Blackman et al.
patent: 5921244 (1999-07-01), Chen et al.
patent: 5968527 (1999-10-01), Litovitz
patent: 6007476 (1999-12-01), Wascher et al.
patent: 6043066 (2000-03-01), Mangano et al.
patent: 6083149 (2000-07-01), Wascher et al.
patent: 6099459 (2000-08-01), Jacobson
patent: 6238899 (2001-05-01), Blackman et al.
patent: 6239145 (2001-05-01), Utsumi et al.
patent: 6261831 (2001-07-01), Agee
patent: 6315978 (2001-11-01), Grissom et al.
patent: 6322676 (2001-11-01), Leddy et al.
patent: 6353763 (2002-03-01), George et al.
patent: 6355166 (2002-03-01), Amarasinghe et al.
patent: 6391895 (2002-05-01), Towart et al.
patent: 6403553 (2002-06-01), Opitz et al.
patent: 2001/0044643 (2001-11-01), Litovitz
patent: WO 00/04951 (2000-02-01), None
Scaiano, Cozens, and McLean, “Model for the rationalization of magnetic field effects in vivo. Application of the radical pair mechanism to biological systems”, Photochemistry and Photobiology, vol. 59, No. 6, pp 585-589, 1994.
Schulten, “Magnetic Field Effects in Chemistry and Biology”, Festkorperprobleme (Advances in Solid State Physics), vol. XXII, Vieweg, Braunschweig, 1982.
Stass, Woodward, Timmel, Hore, McLauchlan, “Radiofrequency magnetic field effects on chemical reaction yields”,Chemical Physics Letters 329 (2000) pp 15-22.
Steller, “Mechanisms and Genes of Cellular Suicide”, Science, vol. 267(5203), Mar. 10, 1995, pp 1445-1449.
Till, Timmel, Brocklehurst, Hore, “The influence of very small magnetic fields on radical recombination reactions in the limit of slow recombination”, Chemical Physics Letters 298 (1998) pp 7-14.
Timmel, Cintolesi, Brocklehurst, Hore, “Model calculations of magnetic field effects on the recombination reactions of radicals with anisotropic hyperfine interactions”, Chemical Physics Letters 334 (2001) pp 387
Gilbert Samuel G.
Law Office of Timothy E. Siegel
Siegel Timothy E.
LandOfFree
Magnetic field enhancement of tumor treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Magnetic field enhancement of tumor treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Magnetic field enhancement of tumor treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3254561